Log in to search using one of your social media accounts:

 

Advanced Thyroid Cancer Gene Study Reveals Therapy Possibilities Advanced Thyroid Cancer Gene Study Reveals Therapy Possibilities
In the largest study of advanced thyroid cancer genetics to date, researchers have found clues to help identify potential candidates for immunotherapy and lenvatinib, and novel mechanisms of progression.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 2, 2018 Category: Cancer & Oncology Tags: Diabetes & Endocrinology News Source Type: news

AstraZeneca Wins U.S. Approval for First-line Use of Lung Cancer Drug AstraZeneca Wins U.S. Approval for First-line Use of Lung Cancer Drug
U.S. regulators have expanded use of AstraZeneca's lung cancer drug Tagrisso to include initial treatment of patients with a specific genetic mutation, the company said on Wednesday.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 20, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Is IO Monotherapy the New Standard of Care in Advanced NSCLC? Is IO Monotherapy the New Standard of Care in Advanced NSCLC?
Merck has released provocative but limited findings from the KEYNOTE-042 trial that indicate better outcomes for first-line pembrolizumab vs standard chemotherapy in advanced non-small cell lung cancer (NSCLC).Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 11, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

More High-Risk Prostate Cancer Now in the US Than Before More High-Risk Prostate Cancer Now in the US Than Before
More men are presenting with higher-grade, more invasive prostate cancer in the wake of 2012 recommendations not to use the prostatic-specific antigen test for routine screening.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 27, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Insurance Exec to Oncologists: Take Financial Toxicity Vow Insurance Exec to Oncologists: Take Financial Toxicity Vow
The runaway cost of cancer care could be partly addressed by oncologists'appreciating financial toxicity as much as actual treatment toxicity, said a presenter at the National Comprehensive Cancer Network annual meetingMedscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 27, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

H pylori Eradication Benefits Patients With Early Gastric Cancer H pylori Eradication Benefits Patients With Early Gastric Cancer
Patients with early gastric cancer treated for Helicobacter pylori had a lower incidence of metachronous gastric cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 21, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Medicare Will Cover Advanced Genetics Testing in Cancer Patients Medicare Will Cover Advanced Genetics Testing in Cancer Patients
CMS has finalized its coverage for next-generation sequencing (NGS) testing, and patients with cancer who meet the criteria will be reimbursedMedscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 19, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Genetic Mutations and Prostate Cancer: Screening Recommendations Genetic Mutations and Prostate Cancer: Screening Recommendations
In light of recently published data, Dr David Graham suggests potential approaches to prostate cancer screening that incorporate genetic test results.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 14, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

' Unethical': Cancer Care Bills Inflated 5 to 15 Times'Unethical': Cancer Care Bills Inflated 5 to 15 Times
Some medical centers providing cancer care are charging 5 to 15 times more than the Medicare allowable amount; this looks like price gouging and is unethical, say researchers.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 27, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Europe Says No to Neratinib for Breast Cancer Europe Says No to Neratinib for Breast Cancer
The European committee recommended against approval of neratinib (Nerlynx) for breast cancer, even though the drug has been approved in the United States.International Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 23, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Overlooked Biomarker May Predict Cancer Immunotherapy Response Overlooked Biomarker May Predict Cancer Immunotherapy Response
Dr David Kerr on data showing that tumors with extensive aneuploidy may not benefit as much from immune checkpoint blockade.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 15, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

More Than Half of UK Docs Support Assisted Dying More Than Half of UK Docs Support Assisted Dying
The British Medical Association has long been opposed to assisted dying, but a recent poll found that 55% of physicians would support its becoming legal in defined circumstances.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 8, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

New Pattern in Gastric Cancer: One Type Increasing in US New Pattern in Gastric Cancer: One Type Increasing in US
One type of gastric cancer is on the increase, especially among individuals younger than 50 years. Women are more at risk than men.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 31, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Survival After Breast Cancer'Unaffected by BRCA Status'Survival After Breast Cancer'Unaffected by BRCA Status '
The likelihood that young women survive primary breast cancer is unaffected by whether or not they carry mutations in the BRCA gene, say UK researchers in a 10-year follow-up study.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 19, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Rhabdomyosarcoma Not a'Muscle' Cancer After All Rhabdomyosarcoma Not a'Muscle' Cancer After All
Rhabdomyosarcoma does not arise from immature muscle cells as previously believed but from endothelial progenitor cells, and this could have implications for new therapies.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 15, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA Expands Use of Denosumab to Myeloma Patients FDA Expands Use of Denosumab to Myeloma Patients
Amgen Inc said on Friday that the U.S. Food and Drug Administration approved its drug, Xgeva, to prevent fractures in patients with multiple myeloma.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 8, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Hormonal Therapy in Advanced Endometrial Cancer Hormonal Therapy in Advanced Endometrial Cancer
This meta-analysis may finally clarify which patients are most likely to respond to hormonal therapy.Medscape (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 15, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

New Potential Drug Therapy for AI-Associated Arthralgia New Potential Drug Therapy for AI-Associated Arthralgia
The anti-depressant duloxetine effectively reduced musculoskeletal symptoms early in the course of treatment with aromatase inhibitors for early-stage breast cancer.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 15, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Viewpoint Source Type: news

Second Cancers Common in Survivors, Especially Older Adults Second Cancers Common in Survivors, Especially Older Adults
Second cancers affect about 25% of survivors 65 years and older, but patients with cancer who have had a prior malignancy are regularly excluded from clinical trials.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 22, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Prostate Cancer Care Is'Changing Rapidly': ESMO 2017 Prostate Cancer Care Is'Changing Rapidly': ESMO 2017
Exciting research presented at ESMO 2017 will likely affect clinical practice in metastatic prostate cancer, says Dr Johann de Bono.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 17, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

FDA: Don't Remove Uterine Fibroids With Ultrasonic Aspirators FDA: Don't Remove Uterine Fibroids With Ultrasonic Aspirators
The agency's nonbinding recommendation points to the same risk posed by power morcellators -- the inadvertent dispersion of occult cancer. ACOG disagrees with the new guidance.News Alerts (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 31, 2017 Category: Cancer & Oncology Tags: Ob/Gyn & Women ' s Health News Alert Source Type: news

' Important' Progress in Gynecologic Cancers: ESMO 2017'Important' Progress in Gynecologic Cancers: ESMO 2017
Dr Banerjee discusses advances in ovarian and cervical cancers presented at ESMO 2017.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 30, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Two Things That Go Together: Yoga and Advanced Lung Cancer Two Things That Go Together: Yoga and Advanced Lung Cancer
Participating in a yoga program while undergoing radiation therapy improved physical functioning and mental in NSCLC patients, and improved vitality in caregivers.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 23, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Ipi Plus Nivo for Melanoma Patients With Brain Metastases Ipi Plus Nivo for Melanoma Patients With Brain Metastases
Two recent ASCO abstracts show important results, possibly practice-changing, on immunologic treatment in melanoma patients with brain metastases.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 20, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Sperm Banking Underutilized in Young Male Cancer Patients Sperm Banking Underutilized in Young Male Cancer Patients
Fertility preservation is an important aspect of cancer care, but young male cancer patients are underutilizing sperm banking.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 19, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

& quot;Massive & quot; Suffering: Pain Relief in Less Affluent Countries & quot;Massive & quot; Suffering: Pain Relief in Less Affluent Countries
In much of the world, patients suffering from serious illness and injury have little to no access to palliative care and adequate pain relief.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 18, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Price of Cancer Drugs Rises After Launch, Unfazed by Market Price of Cancer Drugs Rises After Launch, Unfazed by Market
The cost of oncology drugs, with few exceptions, continues to increase after they enter the market, and in the absence of any tangible reasons for the increase.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 13, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

First-Line Doxorubicin for Advanced Sarcoma, Not Combo? First-Line Doxorubicin for Advanced Sarcoma, Not Combo?
Doxorubicin should remain first-line therapy for patients with soft-tissue sarcoma, conclude trialists who compared it with a gemcitabine and docetaxel combination.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 27, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

New Guidelines for Managing CAR T-Cell Acute Toxicities New Guidelines for Managing CAR T-Cell Acute Toxicities
Researchers at MD Anderson have developed a framework to help recognize and manage unique acute toxicities associated with CAR T-cell therapy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 21, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Imatinib a Double-Edged Sword for Pregnant CML Patients Imatinib a Double-Edged Sword for Pregnant CML Patients
On the one hand, imatinib keeps the CML in check; on the other hand, it carries a risk for fetal congenital malformation if taken during pregnancy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 19, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Severe Health Problems Plague Survivors of Childhood CA Severe Health Problems Plague Survivors of Childhood CA
Specialized healthcare delivery is needed for diverse subgroups of adult cancer survivors with complex medical needs, say researchers.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 18, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

R & D Investment Does Not Justify High Cost of Cancer Drugs R & D Investment Does Not Justify High Cost of Cancer Drugs
A new analysis found that the revenue from cancer drugs greatly exceeds the investment to develop them.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 11, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Lasker Awards Go to HPV Vaccine Researchers, Planned Parenthood Lasker Awards Go to HPV Vaccine Researchers, Planned Parenthood
A third award was for research on nutrient-activated TOR (target of rapamycin) proteins that regulate cell growth.News Alerts (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 6, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Expanding Germline Analyses to Prevent and Treat Cancers Expanding Germline Analyses to Prevent and Treat Cancers
An approach that used paired tumor-normal sequencing detected more inherited actionable gene mutations compared to clinical guideline-based testing.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 6, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Outreach Efforts to Improve CRC Screening Rates Fall Short Outreach Efforts to Improve CRC Screening Rates Fall Short
Efforts to improve screening for colorectal cancer (CRC), either with FIT testing or colonoscopy, did improve uptake but fell short of ideal targets.885204Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 5, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Jack West, MD: Top Five Lung Cancer Abstracts at ESMO 2017 Jack West, MD: Top Five Lung Cancer Abstracts at ESMO 2017
Lung cancer specialist Dr Jack West previews the most important lung cancer studies being presented at the ESMO 2017 Congress in Madrid.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 5, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Increase in CRC Deaths in Under-55s Confined to Whites Increase in CRC Deaths in Under-55s Confined to Whites
The increase in deaths from colorectal cancer (CRC) among younger adults (younger than 55 years) that has been recently highlighted is seen only among whites, not in blacks or other races.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 8, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Pembrolizumab, Larotrectinib Point to Future of Precision Medicine Pembrolizumab, Larotrectinib Point to Future of Precision Medicine
With the examples of pembrolizumab and larotrectinib, Dr Markman discusses how precision cancer medicine will likely change the landscape of cancer therapy.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 8, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

FDA OKs Nivolumab in Metastatic CRC Subtype FDA OKs Nivolumab in Metastatic CRC Subtype
The FDA has given accelerated approval to nivolumab for the treatment of microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 1, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

ASCO Adds MammaPrint to Breast Cancer Guideline ASCO Adds MammaPrint to Breast Cancer Guideline
In an update to its 2016 guideline, the American Society of Clinical Oncology (ASCO) recommends how to use the MammaPrint test to reduce adjuvant chemotherapy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 11, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA Clears Haegarda to Prevent Hereditary Angioedema Attacks FDA Clears Haegarda to Prevent Hereditary Angioedema Attacks
Haegarda is the first C1 esterase inhibitor (human) for at-home subcutaneous administration for the prevention of hereditary angioedema attacks in adolescents and adults.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 23, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Good IDEA: Drop Adjuvant Chemo From 6 to 3 Months in CRC Good IDEA: Drop Adjuvant Chemo From 6 to 3 Months in CRC
Dr John Marshall reports on the practice-changing results of the IDEA study in stage III colorectal cancer looking at duration of adjuvant chemotherapy, as presented at the ASCO plenary session.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 12, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

First Look at New CDK 4/6 Data in Metastatic Breast Cancer First Look at New CDK 4/6 Data in Metastatic Breast Cancer
ASCO 2017 featured a number of important studies looking at the role of CDK 4/6 inhibitors in patients with hormone receptor-positive, HER2-negative metastatic breast cancer.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 5, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Prostate Cancer Diagnoses Fall as Use of PSA Test Declines Prostate Cancer Diagnoses Fall as Use of PSA Test Declines
Incidence rates of prostate cancer in the US are dropping, reflecting the declining use of the PSA test, but this leaves a huge amount undetected, warn experts.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 23, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

EPA Data Reveal Ties Between Environment, Cancer Rates EPA Data Reveal Ties Between Environment, Cancer Rates
New research using Environmental Protection Agency data shows that the overall environmental quality of a geographic location is associated with cancer incidence.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 9, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Untreated Breast Cancers Do Not Spontaneously Vanish Untreated Breast Cancers Do Not Spontaneously Vanish
Contrary to some suggestions that have been made in recent years, untreated breast cancers do not regress or disappear if left untreated.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 9, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Avelumab: Another Immunotherapy for Bladder Cancer Avelumab: Another Immunotherapy for Bladder Cancer
Avelumab has been approved in the US for second-line use in urothelial cancer, making it the fourth immunotherapy with this indication.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 9, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

G-CSF Use in Small Cell Lung Cancer: New Data'Comforting'G-CSF Use in Small Cell Lung Cancer: New Data'Comforting '
Although patients with SCLC given granulocyte colony-stimulating factors during chemo-radiotherapy had an increased risk for hematologic complications, the drugs can be used safely, say researchers.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 9, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Questions Over'Flu Jab' in Lung Cancer Patients on PD Inhibitors Questions Over'Flu Jab' in Lung Cancer Patients on PD Inhibitors
Patients with cancer receiving immune checkpoint inhibitors could be at increased risk for adverse events compared with the general population if they are given a yearly flu jab, say Swiss researchers.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 8, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

PD-Inhibitor Benefits'Continue Beyond Progression' in NSCLC PD-Inhibitor Benefits'Continue Beyond Progression' in NSCLC
Non-small cell lung cancer patients can benefit from immunotherapy even after progression, from both drug continuance and the ongoing effect of prior treatment on salvage therapy, reveal two studies.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 8, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news